American Funds®

  • Forms
  • MY ACCOUNTS
  • INVESTMENTS
  • INSIGHTS
  • PRODUCTS
  • PLANNING
  • SERVICE & SUPPORT

GROWTH FUNDS

®

All Holdings

BACK TO FUND'S DETAIL PAGE
No holdings data is available at this time.
449 Total Holdings:
As of 12/31/15 (updated quarterly, upon availability).
All Holdings: 1 - 15 of 449
Asset Type
Novo Nordisk A/S, Class B Equity 97,113,991 $5,582,149,494.00 4.54%
Novartis AG Equity 30,484,832 $2,605,739,628.00 2.12%
SoftBank Group Corp. Equity 46,554,000 $2,346,058,498.00 1.91%
Prudential PLC Equity 103,553,984 $2,318,356,992.00 1.89%
Baidu, Inc., Class A (ADR) Equity 11,682,269 $2,208,416,132.00 1.8%
Barclays PLC Equity 650,394,039 $2,105,116,771.00 1.71%
AIA Group Ltd. Equity 333,484,600 $1,986,753,882.00 1.62%
Associated British Foods PLC Equity 40,015,838 $1,969,706,668.00 1.6%
HDFC Bank Ltd. Equity 97,275,033 $1,944,393,772.00 1.58%
Bayer AG Equity 14,758,566 $1,851,629,133.00 1.51%
Taiwan Semiconductor Manufacturing Co., Ltd. Equity 378,385,649 $1,632,762,932.00 1.33%
Nintendo Co., Ltd. Equity 11,325,300 $1,559,061,764.00 1.27%
Murata Manufacturing Co., Ltd. Equity 10,508,126 $1,508,196,704.00 1.23%
Alibaba Group Holding Ltd. (ADR) Equity 18,442,732 $1,498,840,830.00 1.22%
Airbus Group SE, non-registered shares Equity 22,163,000 $1,488,101,031.00 1.21%
All Holdings: 1 - 15 of 449

Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value.

Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses and summary prospectuses, which can be obtained from a financial professional and should be read carefully before investing.

Investing outside the United States involves risks, such as currency fluctuations, periods of illiquidity and price volatility, as more fully described in the prospectus. These risks may be heightened in connection with investments in developing countries.

  1. Excludes certain securities in initial period of acquisition.

For more information about the risks associated with each fund, go to its detailed fund information page or read the prospectus.